يعرض 1 - 10 نتائج من 24 نتيجة بحث عن '"Caitlin M Gillis"', وقت الاستعلام: 0.92s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Collège Doctoral, Sorbonne Université (SU), Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Stanford School of Medicine [Stanford], Stanford Medicine, Stanford University-Stanford University, This work was supported by a Jeunes Chercheuses/Jeunes Chercheurs grant from the Agence National de la Recherche (ANR-16-CE15-0012, to FJ). The Phenomin project receives funds from the ANR under the framework 'Investissements d'Avenir' labelled ANR-10-INBS-07 PHENOMIN. PB acknowledges support from the European Research Council (ERC)–Seventh Framework Program (ERC-2013-CoG 616,050), Institut Pasteur and INSERM (Institut National de la Santé et de la Recherche Médicale), SJG from NIH grant R01 AI165373, CMG was supported by a stipend from the Pasteur – Paris University (PPU) International PhD program and by the Institut Carnot Pasteur Maladies Infectieuses, and LLR from an ATIP-Avenir grant from the INSERM and the Fondation pour la Recherche Médicale (FRM EQU202103012566)., ANR-16-CE15-0012,PlanA,Rôle des plaquettes et leurs interactions dans les réactions anaphylactiques(2016), ANR-10-INBS-0007,PHENOMIN,INFRASTRUCTURE NATIONALE EN PHENOGENOMIQUE SOURIS(2010), European Project: 616050,EC:FP7:ERC,ERC-2013-CoG,MYELOSHOCK(2014)

    المصدر: Allergy
    Allergy, In press, ⟨10.1111/all.15738⟩

  3. 3
  4. 4
  5. 5
  6. 6

    المساهمون: University of Texas at Austin [Austin], Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Neuropathologie expérimentale - Experimental neuropathology, Institut Pasteur [Paris]-Université Paris Descartes - Paris 5 (UPD5), Université de Limoges (UNILIM), Regeneron Pharmaceuticals [Tarrytown], Dartmouth College [Hanover], University of Michigan [Ann Arbor], University of Michigan System, University of California [Los Angeles] (UCLA), University of California, This work was supported by the Clayton Foundation, by the European Research Council (ERC)—Seventh Framework Program (ERC-2013-CoG 616050 to P.B.), by the Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale (INSERM). P.M.T was supported by the National Institutes of Health (R01GM104130), National Science Foundation (CBET 1804313) and the Albert M. Mattocks Chair. A.J.M. was supported by NIH DP5-OD019815. C.M.G was supported partly by a stipend from the Pasteur–Paris University (PPU) International PhD program and by the Institut Carnot Pasteur Maladies Infectieuses. D.S. benefited from a stipend (Poste d’accueil) provided by AP-HP, Paris, France and by the Institut Pasteur, Paris, France., European Project: 616050,EC:FP7:ERC,ERC-2013-CoG,MYELOSHOCK(2014), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP)-Université Paris Descartes - Paris 5 (UPD5), University of California (UC)

    المصدر: Nature Communications
    Nature Communications, Nature Publishing Group, 2019, 10 (1), pp.5031. ⟨10.1038/s41467-019-13108-2⟩
    Nature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
    Nature communications, vol 10, iss 1
    Nature Communications, 2019, 10 (1), pp.5031. ⟨10.1038/s41467-019-13108-2⟩

    وصف الملف: application/pdf

  7. 7

    المصدر: Nature communications, vol 10, iss 1
    Nature Communications
    Nature Communications, Vol 10, Iss 1, Pp 1-1 (2019)

    وصف الملف: application/pdf

  8. 8
  9. 9
  10. 10

    المساهمون: Jönsson, Friederike, Role of myeloid cells, their mediators and their antibody receptors in allergic shock (anaphylaxis) using humanized mouse models and clinical samples - MYELOSHOCK - - EC:FP7:ERC2014-09-01 - 2019-08-31 - 616050 - VALID, Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Inflammation, Chimiokines et Immunopathologie [Châtenay-Malabry], Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Chimie des Biomolécules - Chemistry of Biomolecules, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon [AP-HP], Université Paris Diderot - Paris 7 (UPD7), Hôpital Louis Mourier - AP-HP [Colombes], Recherche Clinique ville-hôpital, Méthodologies et Société (REMES), Hôpital Lariboisière-Fernand-Widal [APHP], Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Histopathologie humaine et Modèles animaux, Institut Pasteur [Paris] (IP), Hôpital Saint-Louis, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Hôpital Foch [Suresnes], Lab Excellence Inflamex, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), The NASA study was funded by AP-HP (Direction de la Recherche Clinique et de l’Innovation) through a 'Contrat de Recherche Clinique 2011' to S.C.-M. by INSERM and the French Ministry of Health (Direction Générale de l’Offre de Soin, Paris, France) through a 'Recherche Clinique translationnelle 2012' grant to P.B., by the European Research Council (ERC)–Seventh Framework Program (ERC-2013-CoG 616050) to P.B., by the Institut Pasteur, and by the INSERM. A.G.-C. benefited from a stipend provided by AP-HP, Paris, France and by the Institut Pasteur, Paris, France and from a grant provided by INSERM, SFAR (Société Française d’Anesthésie et de Réanimation), and SRLF (Société de Réanimation de Langue Française) through the 'Bourse de Recherche du Comité d’interface INSERM-SFAR-SRLF 2012.' C.M.G. was supported partly by a stipend from the Pasteur-Paris University (PPU) International PhD program and by the Institut Carnot Pasteur Maladies Infectieuses. P.B. benefited from an additional support from AP-HP through a 'Contral Local d’Interface 2014' and the 'Département Hospitalo-Universitaire' (DHU) FIRE. The sponsor of the NASA study was the Direction de la Recherche Clinique et de l’Innovation de l’AP-HP (France). F.J. is an employee of the CNRS., We are thankful to the team of the Pharmacoepidemiology Center of the Assistance Publique-Hôpitaux de Paris (AP-HP) and, in particular, N. Yelles, K. Chandirakumaran, and I. Younes at the Bichat Hospital for help with the NASA study logistics. We thank all clinicians from the NASA study group for help with patient recruitment, in particular, V. Faitot, A. Mebazaa, J. Mantz (deceased), S. Roche, C. Chahine, J. Bresson, and A. Mignon. From the Institut Pasteur, Paris, France, we thank B. Iannascoli for help with antibody purification, D. A. Mancardi for flow cytometry setups, F. Bonhomme for mass and nuclear magnetic resonance analyses of carboxylated rocuronium and suxamethonium, and B. Baron and P. England for MST. We thank V. Guérineau (Institut de Chimie des Substances Naturelles, Gif-sur-Yvette, France) for the mass analyses of bioconjugates and M. Parent, S. Peltier, L. Gaillanne, and C. S. Louis-Augustin (Immunology Laboratory, Bichat Hospital, Paris) for help with sample management and immunology diagnostic tests. We thank M. Pallardy (Toxicology department, UFR de Pharmacie de l’Université Paris-Sud and INSERM UMR996) for discussions on NMBA allergy., European Project: 616050,EC:FP7:ERC,ERC-2013-CoG,MYELOSHOCK(2014), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Institut Pasteur [Paris], Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: Science Translational Medicine
    Science Translational Medicine, 2019, 11 (500), pp.eaat1479. ⟨10.1126/scitranslmed.aat1479⟩
    Science Translational Medicine, American Association for the Advancement of Science, 2019, 11 (500), pp.eaat1479. ⟨10.1126/scitranslmed.aat1479⟩

    وصف الملف: application/pdf